|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-3-26
|
|
pubmed:abstractText |
This study is performed to evaluate the response rate, time to progression and safety of the combination chemotherapy with weekly paclitaxel plus cisplatin in advanced gastric and gastro-esophageal cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1465-3621
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
237-43
|
|
pubmed:meshHeading |
pubmed-meshheading:19264768-Adult,
pubmed-meshheading:19264768-Aged,
pubmed-meshheading:19264768-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19264768-Cisplatin,
pubmed-meshheading:19264768-Disease Progression,
pubmed-meshheading:19264768-Drug Administration Schedule,
pubmed-meshheading:19264768-Esophageal Neoplasms,
pubmed-meshheading:19264768-Esophagogastric Junction,
pubmed-meshheading:19264768-Female,
pubmed-meshheading:19264768-Humans,
pubmed-meshheading:19264768-Male,
pubmed-meshheading:19264768-Middle Aged,
pubmed-meshheading:19264768-Nausea,
pubmed-meshheading:19264768-Neutropenia,
pubmed-meshheading:19264768-Paclitaxel,
pubmed-meshheading:19264768-Stomach Neoplasms,
pubmed-meshheading:19264768-Survival Rate,
pubmed-meshheading:19264768-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Multi-center phase II trial of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric and gastro-esophageal cancer.
|
|
pubmed:affiliation |
Department of Medical Oncology, Wuxi 2nd Hospital, Nanjing Medical University, People's Republic of China.
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase II
|
